https://www.selleckchem.com/pr....oducts/Temsirolimus.
45; 95% CI 1.62-3.73), lower respiratory tract RVI (aHR 3.45; 95% CI 2.15-5.52), and influenza (aHR 3.57; 95% CI 1.75-7.26) were associated with graft failure or death. In this cohort of SOT recipients, RVI caused important morbidity and may affect long-term outcomes, underlying the need for improved preventive strategies. The objectives of this retrospective cohort study are to describe rates of adherence to laboratory testing 6months to 3years post-liver transplantation and to examine demographic and clinical factors related to l
Like
Comment
Share
